Two experiments were performed to examine the ability of human pancreatic growth hormone releasing factor (hGRF) administration to stimulate endogenous growth hormone (GH) secretion in lambs. Each study utilized eight Dorset wether lambs in replicated 4 X 4 Latin square experiments. Growth hormone response (integrated area under the curve for 150 min post-injection) for O, 1, 5 and 10 #g hGRF/kg body weight averaged 13, 23, 92 and 134 units, respectively. While the 1-vg hGRF dose was not different (P>.OS) than the response to saline injection, there was an increased (P<.01) GH response to 5 or 10 vg hGRF. Overall the GH response increased in a log dose-response fashion. There was distinct variation between lambs in their response to hGRF. Study II examined the optimal method to administer 40 vg hGRF/kg body weight to maximize GH concentration over 24 h. Continuous infusion (CI) was compared with eight (8X), four (4X), or two (2• injections/d. Hourly blood samples were obtained from all lambs. Growth hormone response (area under the curve for 24 h) was 162, 305, 306 and 220 units for CI, 8• 4X and 2X, respectively. Growth hormone response to C1 was inferior to discrete injections, and the GH response to 4X or 8X waS superior to 2X/d. Results demonstrate that, in spite of lamb-to-lamb variation, one can utilize exogenous hGRF to enhance GH secretion in lambs. Thus, the ability of exogenous hGRF to enhance growth performance merits further study.
Introduction
There is ample evidence that exogenous growth hormone (GH) administration can enhance growth performance by livestock. Machlin (1972) and Chung et al. (1985) demonstrated significant increases in growth rate and feed conversion efficiency by administration of porcine GH to young swine. Muir et al. (1983) observed no increase in growth rate of GH-treated lambs, but a significant increase in feed conversion efficiency and a significant reduction in carcass lipid (compared with control lambs) were evident. More recently, Wolfrom et al. (1985) demonstrated that a higher dose of GH (than that utilized by Muir et al., 1983 ) could lead to increased growth rate and feed conversion efficiency in lambs, which agrees with findings of Johnson et al. (1985) . These studies demonstrated the practical benefit that may exist if one could enhance secretion of endogenous GH in meat animals. Recent investigations suggest that GH secretion can be elicited in many animals, including rats (Wehrenberg et al., 1982) , steers (Moseley et al., 1984 (Moseley et al., , 1985 and sheep (Ptouzek et al., 1984; Hart et al., 1985; DellaFera et al., 1986a) , through the use of growth hormone releasing factor (GRF). However, the responses to exogenous GRF have been rather short-lived and a true dose-responsiveness to GRF in sheep has not been determined. The objectives of the present study were to determine an optimum dose (Study I) and pattern of administration (Study II) of hGRF to maximize the concentration of GH in plasma of wether lambs over a 24-h period. Such data are essential to determine if GRF might be a potential growth-promoting agent in livestock.
Experimental Procedures
Animals and Experimental Design. In Study I, eight Dorset wethers were assigned to four treatments in a replicated Latin square design that was balanced for carryover effects. Lambs were housed in metabolism crates in a facility maintained at 20 C. Animals were weighed prior to being placed in the crates and weekly thereafter. At the onset of the trial lambs averaged 41.3 kg body weight (BW). A complete pelleted diet (16% crude protein) was fed ad libitum during the 8 d of the trial, except for a complete fast from 30 min prior to human pancreatic GRF (hGRF) injection until 6 h later.
Lambs were fitted with indwelling jugular cannulae 24 h prior to the start of the experiment. Treatments were 0, 1, 5 and 10/ag hGRF (1--44 amide~)/kg BW. The hGRF was solubilized daily in sterile physiological saline and was administered at 1000 by sc injection (2 ml). Each lamb received each treatment with a 1-d recovery period between treatment days. Blood samples (5 ml) were collected at -30, -15, 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, 150, 180, 240 and 300 min post-injection. Sterile physiological saline (3 ml) containing heparin (10 units/ml) was used to flush the catheter after each sample. After the 300-rain sample was taken and, on the interim day, the catheters were flushed with heparinized saline (200 units heparin/ml) containing Gentamicin 7. Plasma was harvested from each blood sample and fIozen at -20 C until assayed.
In Study II, eight Dorset wethers (including seven lambs from Study I and an additional lamb of similar age) were assigned to treatments in a balanced Latin square design, replicated once. One lamb was substituted because of failure to respond to any dose of GRF in Study I. Lambs averaged 47.6 kg BW, and were managed as in Study I, except that feed was available ad libitum during the entire injection and sampling period. figure 4. Blood samples (5 ml) were obtained at -15 and 0 min pre-injection, 15 min post-injection and every 60 min thereafter for 24 h. All treatments commenced at 1000. As in Study I, there was a 1-d recovery period between each injection and bleeding day, with prophylactic antibiotic (Gentamicin)maintenance of the indwelling cannulae. Plasma was stored (-20 C) until assayed.
During the first day of Study II, one lamb developed urinary calculi and was replaced. Consequently, an additional day was added to the experiment to complete the design for that square of four lambs.
GH Radioimmunoassay. Iodination grade
ovine GH (NIAMDD-oGH-I-3; 1.7 IU/mg), biological grade oGH (NIH-GH-SII, .56 IU/mg), and antiserum to ovine GH (NIAMDD-antioGH-2) were utilized for GH radioimmunoassay 9 .
Five micrograms oGH was reacted with 1 mCi Na12SI 1~ in the presence of 1 /ag iodogen reagent 11 for 4 min in 60 #1 25 mM Tris with .154 M NaC1 pH 7.2 at 23 C. The iodinated protein was separated from aggregated protein and free iodine by chromatography on a Sephadex G-75 column into 25 mM Tris, .154 M NaCI buffer containing .1% BSA. The hormone fraction that was utilized for radioimmunoassay was selected on the basis of maximum precipitation with 10% trichloroacetic acid (TCA), and maximum immunoprecipitation with excess first antibody. Any hormone less than 98% precipitable by TCA or 80% immunoprecipitable was not used. Specific activities of the trace used in this study averaged 86.4 #Ci/t/g. Fifty or 100/~1 of lamb plasma was added to 100 /al of antiserum, 100 #1 of ll2S-oGH (.08 ng) and sufficient buffer (25 mM Tris, .154 M NaC1, .1% BSA at pH 7.2) to make a 500-/~1 primary incubation. Primary incubation was conducted for 48 h at 23 C, followed by addition of 100/~1 of 1% normal rabbit serum 7 and 100 #1 of goat antirabbit gamma globulin 12. All tubes were then incubated at 5 C for 24 h. Two milliliters of assay buffer (5 C) was added to each tube, tubes were centrifuged at 1,700 • g for 30 min, the supernatant solutions were poured away from the pellets, and tubes were counted in a Biogamma Counter 13 at 69% efficiency. All assay data were transformed using the logqogit program of English (1981) . Intra-and inter-assay coefficients of variation for a pooled sample of lamb plasma, which was included in every assay, were less than 10%, and the oGH radioimmunoassay was validated to assure adequate (90 to 110%) recovery of hormone added to ovine plasma, and to demonstrate that the inhibition curves for plasma were parallel to the standard curve. Cross-reactivity of this antiserum with other pituitary hormones was less than 1%.
Statistical Analysis. For each study, plasma GH concentrations were plotted against time for each lamb-day. The area under the response curve (AUC) for 150 min (Study I) or for 24 h (Study II) was determined by weighing paper tracings for each lamb-day, and was utilized as the dependent variable. Although samples were collected for 300 min in Study I, the AUC was determined for 150 min because this was the time required for the mean GH concentration in treated animals to decrease to the level of the saline-injected control Iambs. Treatment, period and lamb effects were determined using the Statistical Analysis System (SAS, 1982) according to a Latin square design; pre-planned orthogonal contrasts were conducted to detect differences among treatments.
After analysis of GH in plasma from Study I, it was obvious that on d 4 the saline-control and 10/ag GRF injections were reversed in lambs from square one. Therefore, these two iambs received the same treatment on two separate days. With the advice of Dr. David F. Cox of the Department of Statistics, Iowa State University, the data were recoded to indicate the correct treatment and analyzed using all data. It is prudent to state that the statistical interpretation of the results was the same regardless of whether all data were utilized or the two lamb-days were omitted from the analysis.
R esu Its
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in their ability to respond to the various doses of hGRF (figure 1). Six of eight lambs demonstrated clear hGRF-dose dependent increases in plasma GH, as represented by lamb B of figure 1. One lamb responded equally to the 5-and 10-/ag dose, but not to the saline or 1-/ag dose (data not shown). In addition, it was also evident that one lamb (see A from figure 1) did not respond to any dose of the releasing factor. However, when one examines the mean response of all eight lambs to the various doses of hGRF (figure 2), it is evident that lambs elicit a rapid increase in plasma GH in response to hGRF, but not saline injection. Peak concentrations of GH in plasma were observed between 10 and 15 min post-injection, and the amplitude of the secretory episode was related to the dose of releasing factor administered (figure 2). Higher doses of hGRF elicited a more sustained elevation of plasma GH than did the 1-/ag dose, and GH in plasma of all lambs returned to pre-injection concentrations by 150 min post-administration (figure 2).
Analyses of variance of data from Study I (table 1) indicated that there was a significant day effect, with mean GH concentrations on d 1, 2, 3 and 4 averaging 15, 47, 47 and 70 ng/ml, respectively. Lamb effects also were significant. The main effect of GRF dose was further analyzed by orthogonal contrasts (table 1) . Plasma GH response to 1/ag hGRF/kg BW were not significantly different from saline injections (table 1) . In contrast, 0 and 1/ag hGRF elicited significantly less GH response than did 5 or 10 /~g hGRF/kg BW, and 10/ag was greater than 5 /ag hGRF at a significance level of 11% (table  1) . A more convincing illustration that lambs responded to hGRF in a dose-dependent manner is the plot of the area under the plasma GH response curve relative to the log (base 10) of the hGRF dose (figure 3). These data clearly show a linear dose-response relationship, and there was no evidence for a diminished response at the highest dose utilized.
Study II examined various patterns to administer 40 /ag hGRF-kg body wt-d -1. Plasma GH responses to two, four, eight injections, or CI (figure 4) showed that lambs responded (on average) to every discrete hGRF injection, and that the amplitude of each response was (as in Study 1) somewhat proportional to the dose of hGRF given at that injection. Furthermore, it was observed that a continuous infusion of hGRF into lambs at 1.67 /ag,kg -1-h -1 elicited a constant elevation in plasma GH above baseline concentrations, which were less than 10 ng/ml (figure 4).
Statistical analysis of total GH area under the curve for 24 h showed a tendency (P<.12) for GH concentrations to decrease from d 1 to other days as concentrations averaged 88, 49, 52, 46 and 48 ng/ml for d 1 through 5, respectively (table 2). As in Study I, the responses in lambs Were significantly different from one another and there were differences in total GH responses to the various patterns of administering a single dose of releasing factor. The continuous infusion elicited a significantly lower GH response than did the discrete injections (table 2). Two injections of GRF elicited less GH release than four or eight injections (P<.09), but 4• and 8• did not differ.
Discussion
The present study shows that lambs will respond to hGRF in a dose-dependent manner even though there are six amino acid substitutions between hGRF (Bohlen et al., 1983) and ovine GRF (Brazeau et al., 1984) . The present experiments utilized higher doses of hGRF than studies by Plouzek et al. (1984) , Hart et al. aAverage GH concentrations for 0 to 150 min postinjection for O, 1, 5 and 10 ~g GRF were 8.8, 19.2, 65.8 and 87.0 ng/ml respectively, with SE = 6.2. 1985) or Della-Fera et al. (1986a,b) with sheep; Moseley et al. (1984) with steers or Johke et al. (1984) with cattle. The purpose was to attempt to elicit a higher and more prolonged elevation of plasma GH than previous studies so that a few administrations of releasing factor per 24-h period could increase somatotropin in blood over a significant portion of the day. In addition, from a practical standpoint the current study utilized sc injections rather than iv administration; Johke et al. (1984) and Della-Fera et al. (1986b) have demonstrated a diminished response to sc compared with iv infusion.
The present data do not prove a maximally effective (single administration) dose of hGRF to increase GH in lambs. It is clear that 10 #g GRF/kg BW elicits greater GH than lower doses (figure 2). It is also evident that the GH response increased in a linear relationship on a log-dose basis (figure 3). However, it did not appear that each 20-#g injection elicited a much greater response than 10-#g injections (see 2x vs 4x) when they were compared in Study II (figure Time (h) Figure 4 . Mean concentration of oGH in plasma after two injections (2X 20 #g; at 1000 and 2200), four injections (4• 10 /ag; at 1000, 1600, 2200 and 0400), eight injections (8X 5 /ug; at 1000, 1300, 1600, 1900, 2200, 0100, 0400 and 0700) or a continuous infusion (CI) or 40 pg hGRF'kg -1 body wt'd -1 . Each data point is the mean of eight observations. 4). Consequently, a maximal GRF dose may be in the 10 to 20/ag/kg BW range.
Lamb-to-lamb variation in responsiveness to hGRF has been demonstrated but the cause is not clear. While elevated somatostatin in these lambs at the time of GRF injection is a likely cause for unresponsiveness (Law et al., 1984) , the authors have no proof of this hypothesis. For GRF to enhance significantly growth performance, the great majority of lambs have to respond. Consequently, studies are underway to examine the frequency of responsiveness in a larger population of lambs.
Concentrations of GH increased in Study I (significant day effect) with little change over days in the second experiment. In the first study, lambs were fasted during the 330-min sampling period to reduce eating-related changes (Trenkle and Plouzek, 1985) in plasma somatotropin. It is possible that this daily fast led to increased GH with time. It is also possible (and perhaps more likely) that hGRF stimulated GH aAverage GH concentration over 24 h for CI, 8X, 4• and 2• were 31.5, 65.3, 69.3 and 49.6 ng/ml, respectively, with SE = 4.1.
synthesis (Barinaga et al., 1983) or somatotroph proliferation (Billestrup et al., 1986) , as well as secretion, so that the releasable pool of GH increased on a day-to-day basis. Della-Fera et al. (1986a) observed a decreased responsiveness in young lambs treated with GRF at frequent intervals. In contrast, there was little evidence that lambs became refractory to GRF in the present studies. Even in Study II with administration of hGRF every 3 h, there were consistent increases in plasma GH (figure 4). Perhaps it is related to the fact that a greater dose of releasing factor was utilized in the present experiment, than in that of Della-Fera et al. (1986a) . Moseley et al. (1985) also did not observe a refractoriness in steers treated with frequent microinjections of GRF.
Recently, Clark and Robinson (1985) demonstrated that if properly administered, GRF can increase growth rate and pituitary GH content in normal and in GRF-deficient rats. The current studies establish a method in terms of GRF dose and pattern of administration to increase significantly GH concentrations in blood of wethers. It remains to be proven whether GRF can enhance growth performance in lambs, as well.
